THERAPEUTIC EFFECT OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITOR IN THE MALE GENITAL INFLAMMATION

被引：0
|
作者：
Ohira, Shin [1 ]
Hara, Ryoei [1 ]
Tone, Shigenobu [2 ]
Nagai, Atsushi [1 ]
机构：
[1] Kawasaki Med Sch, Dept Urol, Kurashiki, Okayama, Japan
[2] Tokyo Denki Univ, Grad Sch, Dept Life Sci & Engn, Hatoyama, Saitama, Japan
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2019年 / 95卷
关键词：
D O I：
10.1136/sextrans-2019-sti.193
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O16.1
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [21] A new cancer immunosuppression target: indoleamine 2,3-dioxygenase (IDO). A review of the IDO mechanism, inhibition and therapeutic applications
    Malachowski, WP
    Metz, R
    Prendergast, GC
    Muller, AJ
    DRUGS OF THE FUTURE, 2005, 30 (09) : 897 - 909
  • [22] Indoleamine 2,3-dioxygenase (IDO) - The antagonist of type I interferon-driven skin inflammation?
    Scheler, Marina
    Wenzel, Joerg
    Tueting, Thomas
    Takikawa, Osamu
    Bieber, Thomas
    von Bubnoff, Dagmar
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (06): : 1936 - 1943
  • [23] Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor demonstrates antitumor effect in dogs with urothelial carcinoma
    Iguchi, Takaaki
    Ikeda, Namiko
    Aoki, Susumu
    Qin, Shiyu
    Ohta, Ryosuke
    Koseki, Shoma
    Shibahara, Hayato
    Kako, Takahiro
    Hashimoto, Yuko
    Takahashi, Yousuke
    Takahashi, Naohiro
    Chambers, James
    Uchida, Kazuyuki
    Nishimura, Ryohei
    Nakagawa, Takayuki
    CANCER SCIENCE, 2024, 115 : 105 - 105
  • [24] Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with inflammation in systemic sclerosis
    Rutella, Sergio
    De Santis, Maria
    Bonanno, Giuseppina
    Procoli, Annabella
    Mariotti, Andrea
    Corallo, Maria
    Novarese, Linda
    Bosello, Silvia
    Scambia, Giovanni
    De Cristofaro, Raimondo
    Ferraccioli, Gianfranco
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [25] Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
    Merlo, Lauren M. F.
    Grabler, Samantha
    DuHadaway, James B.
    Pigott, Elizabeth
    Manley, Kaylend
    Prendergast, George C.
    Laury-Kleintop, Lisa D.
    Mandik-Nayak, Laura
    CLINICAL IMMUNOLOGY, 2017, 179 : 8 - 16
  • [26] Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Rohrig, Ute F.
    Reynaud, Aline
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Pojer, Florence
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (19) : 8784 - 8795
  • [27] INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY IS LOW IN MICE RESISTANT TO HYPEROXIA
    MCCREARY, JL
    COURSIN, DB
    WILL, JA
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 889 - 889
  • [28] Pregnancy, indoleamine 2,3-dioxygenase (IDO) and chlamydial abortion: An unresolved paradox
    Entrican, Gary
    Wattegedera, Sean
    Rocchi, Mara
    Wheelhouse, Nicholas
    VETERINARY MICROBIOLOGY, 2009, 135 (1-2) : 98 - 102
  • [29] INDOLEAMINE 2,3-DIOXYGENASE (IDO) AS A NEW IMMUNOLOGICAL MARKER IN KIDNEY TRANSPLANT
    Loiacono, Elisa
    Votta, Barbara
    Amore, Alessandro
    Ranghino, Andrea
    Camilla, Roberta
    Peruzzi, Licia
    Donadio, Maria Elena
    Serriello, Ilaria
    Gallo, Rachele
    Puccinelli, Maria Paola
    Coppo, Rosanna
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 273 - 274
  • [30] Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
    Carvalho, Catarina
    Siegel, David
    Inman, Martyn
    Xiong, Rui
    Ross, David
    Moody, Christopher J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (17) : 2663 - 2674
12345